Evaluation of respiratory problems in children with esophageal atresia
Abstract
Objective: Esophageal atresia (EA) is the most common esophageal anomaly associated with respiratory morbidity in childhood. This study aimed to evaluate respiratory problems in children who underwent surgery for esophageal atresia. Material and Methods: A total of 33 cases with EA were included in the patient group, and 20 cases diagnosed with isolated gastroesophageal reflux disease (GERD) were included in the control group. This case-control study also included observational and analytical evaluations. Respiratory symptoms and findings were recorded. Spirometry was performed to assess lung function, and laboratory tests indicating an allergic condition were examined. Results: In the patient group with a median age of 4.7 years (IQR: 6.7), 84.8% had recurrent or chronic cough, 51.5% had wheezing, 63.6% had a history of respiratory distress in the past year, 24.2% had recurrent pneumonia, and 63.6% had a history of hospitalization due to respiratory problems at least once. Aspiration pneumonia was present in 27.2% of patients, asthma diagnosed by a physician in 33.3%, and tracheomalacia in 18.1%. Asthma, cough, and wheezing were observed at similar rates in both groups, while aspiration pneumonia and hospitalization due to respiratory problems were more common in the patient group. Pulmonary function test (PFT) abnormalities were significantly more common in the EA group compared with the control group (p<0.001). Conclusion: Respiratory problems in EA are based on…
How strong is the evidence?
Evidence Hub reads this as a case-control, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.